首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model
【2h】

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

机译:绵羊模型中可注射的水凝胶特性影响梗塞扩展和梗死后左心室重构的程度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A recent trend has emerged that involves myocardial injection of biomaterials, containing cells or acellular, following myocardial infarction (MI) to influence the remodeling response through both biological and mechanical effects. Despite the number of different materials injected in these approaches, there has been little investigation into the importance of material properties on therapeutic outcomes. This work focuses on the investigation of injectable hyaluronic acid (MeHA) hydrogels that have tunable mechanics and gelation behavior. Specifically, two MeHA formulations that exhibit similar degradation and tissue distribution upon injection but have differential moduli (~8 versus ~43 kPa) were injected into a clinically relevant ovine MI model to evaluate the associated salutary effect of intramyocardial hydrogel injection on the remodeling response based on hydrogel mechanics. Treatment with both hydrogels significantly increased the wall thickness in the apex and basilar infarct regions compared with the control infarct. However, only the higher-modulus (MeHA High) treatment group had a statistically smaller infarct area compared with the control infarct group. Moreover, reductions in normalized end-diastolic and end-systolic volumes were observed for the MeHA High group. This group also tended to have better functional outcomes (cardiac output and ejection fraction) than the low-modulus (MeHA Low) and control infarct groups. This study provides fundamental information that can be used in the rational design of therapeutic materials for treatment of MI.
机译:最近出现了一种趋势,涉及在心肌梗塞(MI)后通过心肌注射包含细胞或无细胞的生物材料来通过生物学和机械作用来影响重塑反应。尽管在这些方法中注入了多种不同的材料,但是很少有材料特性对治疗效果的重要性的研究。这项工作专注于研究具有可调的力学和胶凝行为的可注射的透明质酸(MeHA)水凝胶。具体来说,将两种在注射后表现出相似降解和组织分布但具有不同模量(〜8与〜43 kPa)的MeHA制剂注射到临床上相关的绵羊MI模型中,以评估基于重塑反应的心肌内水凝胶注射的相关有益作用在水凝胶力学上。与对照梗塞相比,两种水凝胶治疗均显着增加了根尖和基底梗塞区域的壁厚。但是,只有高模量(MeHA高)治疗组与对照组相比,统计学上有较小的梗塞面积。此外,对于MeHA High组,正常舒张末期和收缩末期体积减少了。与低模量组(MeHA Low)和对照组相比,该组的功能结局(心输出量和射血分数)也往往更好。这项研究提供了可用于合理设计治疗MI的治疗材料的基本信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号